ICON plc (ADR) (NASDAQ:ICLR)

CAPS Rating: 3 out of 5

The Company is a contract research organization, providing clinical research and development services on a global basis to the pharmaceutical, biotechnology and medical device industries.

Recs

0
Player Avatar money4play (60.57) Submitted: 8/11/2008 3:32:22 PM : Outperform Start Price: $43.67 ICLR Score: -54.64

As big pharma trys to reduce costs of geting products to market they will rely more heavily on outsourcing clinical trials.

Featured Broker Partners


Advertisement